Evidence map›Paper›PMID 25461782›Full record

ArticleBehaviour research and therapy2014

Web-based Mindfulness-based Cognitive Therapy for reducing residual depressive symptoms: An open trial and quasi-experimental comparison to propensity score matched controls.

Sona Dimidjian, Arne Beck, Jennifer N Felder, Jennifer M Boggs, Robert Gallop, Zindel V Segal

Registry-linked trialAbstract readComparative StudyControlled Clinical Trial
In one paragraph

Article in Behaviour research and therapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02190968 (Reducing Residual Depressive Symptoms With Web-based Mindful Mood Balance.), which is not on this map. Cited by 38 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02190968 nacompletednot on this mapstarted 2015, after this paper: background citation

Reducing Residual Depressive Symptoms With Web-based Mindful Mood Balance.

TypeinterventionalSponsorUniversity of TorontoRan2015 to 2018Enrolled460ConditionsMajor Depressive Disorder, Recurrent, in Remission, Depressive SymptomsArmsUsual Depression Care, Mindful Mood Balance
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. A randomized controlled trial of a 14-day mindfulness ecological momentary intervention (MEMI) for generalized anxiety disorder.European psychiatry : the journal of the Association of European Psychiatrists · 2023
    Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Article
  15. Article
  16. An online mindfulness intervention for medical students in South Africa: A randomised controlled trial.The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sona DimidjianDepartment of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO 80309, USA. Electronic address: sona.dimidjian@colorado.edu.
Arne BeckKaiser Permanente Colorado Institute for Health Research, USA.
Jennifer N FelderDepartment of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO 80309, USA.
Jennifer M BoggsKaiser Permanente Colorado Institute for Health Research, USA.
Robert GallopDepartment of Mathematics, West Chester University, USA.
Zindel V SegalDepartment of Psychology, University of Toronto Scarborough, Canada.

Funding

Increasing Access to Depressive Relapse Prophylaxis with Web-Based MBCTR34MH087723 · NIMH · CENTRE FOR ADDICTION AND MENTAL HEALTH · PI SEGAL, ZINDEL · 2010 to 2012
$602k
NIMH NIH HHS R34 MH087723
6 · The paper itself

Abstract

Mindfulness-based Cognitive Therapy (MBCT) has been shown to effectively prevent relapse and reduce residual depressive symptoms (RDS), yet it faces barriers to dissemination. The present study examined Mindful Mood Balance (MMB), the first web-based approach to deliver the core content of MBCT. Of the 107 recurrently depressed individuals screened, 100 elected to enroll in the study and received MMB in an 8-session open trial with 6-month follow-up. Outcomes included depressive symptom severity, rumination and mindful awareness, and program engagement. A quasi-experimental comparison between MMB participants and propensity matched case-controls receiving usual depression care (UDC) (N = 100) also was conducted. The full sample and the subgroup with residual depressive symptoms (N = 42) showed significantly reduced depressive severity, which was sustained over six months, and improvement on rumination and mindfulness. Examination of acceptability of MMB indicated that 42% of participants within the full sample and 36% of the RDS subgroup completed all 8 sessions and 53% within the full sample and 50% within the RDS subgroup completed at least 4 sessions, and that participants engaged with daily mindfulness practice. MMB also was associated with significant reduction in RDS severity as compared to quasi-experimental propensity matched controls. Although the use of a non-randomized design, with potential unmeasured differences between groups, and short interval of clinical follow-up were limitations, findings from this study support the web-based delivery of MBCT and suggest clinical benefits for participants with histories of depression and with RDS, relative to those receiving usual care alone.

Indexed as

Case-Control StudiesChronic DiseaseCognitive Behavioral TherapyDepressionFemaleHumansInternetMajor Depressive DisorderMaleMiddle AgedMindfulnessPropensity ScoreRecurrenceTelemedicineThinkingTreatment OutcomeDisseminationMajor depressive disorderMindfulness-based Cognitive TherapyResidual depressive symptomsWeb-based treatments

Identifiers

PMID25461782
PMCPMC5714615

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.